Canal Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $286K | Sell |
11,866
-42
| -0.4% | -$1.1K | 0.03% | 190 |
|
|
2026
Q1 | $334K | Buy |
+11,908
| New | +$317K | 0.05% | 159 |
|
|
2025
Q4 | – | Sell |
-16,243
| Closed | -$414K | – | 194 |
|
|
2025
Q3 | $414K | Sell |
16,243
-328
| -2% | -$8.1K | 0.06% | 131 |
|
|
2025
Q2 | $402K | Sell |
16,571
-600
| -3% | -$14K | 0.06% | 127 |
|
|
2025
Q1 | $435K | Buy |
+17,171
| New | +$449K | 0.07% | 109 |
|
|
2024
Q4 | – | Sell |
-27,012
| Closed | -$782K | – | 180 |
|
|
2024
Q3 | $782K | Buy |
27,012
+454
| +2% | +$13.2K | 0.12% | 85 |
|
|
2024
Q2 | $743K | Buy |
26,558
+6,328
| +31% | +$174K | 0.13% | 84 |
|
|
2024
Q1 | $561K | Sell |
20,230
-847
| -4% | -$23.5K | 0.09% | 89 |
|
|
2023
Q4 | $607K | Sell |
21,077
-249
| -1% | -$7.53K | 0.11% | 92 |
|
|
2023
Q3 | $707K | Buy |
21,326
+506
| +2% | +$17.9K | 0.14% | 79 |
|
|
2023
Q2 | $764K | Buy |
20,820
+18
| +0.1% | +$701 | 0.15% | 80 |
|
|
2023
Q1 | $849K | Hold |
20,802
| – | – | 0.19% | 75 |
|
|
2022
Q4 | $1.07M | Buy |
20,802
+404
| +2% | +$19.4K | 0.26% | 78 |
|
|
2022
Q3 | $893K | Buy |
20,398
+21
| +0.1% | +$1.02K | 0.26% | 73 |
|
|
2022
Q2 | $1.07M | Buy |
20,377
+27
| +0.1% | +$1.38K | 0.32% | 66 |
|
|
2022
Q1 | $1.05M | Buy |
20,350
+189
| +0.9% | +$9.81K | 0.28% | 68 |
|
|
2021
Q4 | $1.19M | Buy |
20,161
+158
| +0.8% | +$7.83K | 0.29% | 70 |
|
|
2021
Q3 | $860K | Sell |
20,003
-851
| -4% | -$37.7K | 0.25% | 73 |
|
|
2021
Q2 | $817K | Sell |
20,854
-2
| -0% | -$78 | 0.24% | 75 |
|
|
2021
Q1 | $756K | Sell |
20,856
-82
| -0.4% | -$2.91K | 0.26% | 77 |
|
|
2020
Q4 | $771K | Sell |
20,938
-855
| -4% | -$31.4K | 0.29% | 73 |
|
|
2020
Q3 | $759K | Sell |
21,793
-605
| -3% | -$21.2K | 0.33% | 72 |
|
|
2020
Q2 | $695K | Buy |
22,398
+2
| +0% | +$68 | 0.34% | 69 |
|
|
2020
Q1 | $694K | Buy |
22,396
+322
| +1% | +$11K | 0.39% | 63 |
|
|
2019
Q4 | $821K | Sell |
22,074
-833
| -4% | -$29.7K | 0.41% | 65 |
|
|
2019
Q3 | $781K | Sell |
22,907
-610
| -3% | -$22.2K | 0.47% | 59 |
|
|
2019
Q2 | $967K | Buy |
23,517
+1,358
| +6% | +$53.9K | 0.59% | 55 |
|
|
2019
Q1 | $893K | Sell |
22,159
-1
| -0% | -$40 | 0.57% | 56 |
|
|
2018
Q4 | $918K | Buy |
22,160
+194
| +0.9% | +$8.05K | 0.62% | 59 |
|
|
2018
Q3 | $918K | Buy |
21,966
+79
| +0.4% | +$3.04K | 0.52% | 60 |
|
|
2018
Q2 | $753K | Buy |
21,887
+498
| +2% | +$17K | 0.42% | 65 |
|
|
2018
Q1 | $720K | Sell |
21,389
-761
| -3% | -$26.2K | 0.41% | 63 |
|
|
2017
Q4 | $761K | Buy |
22,150
+34
| +0.2% | +$1.16K | 0.42% | 63 |
|
|
2017
Q3 | $749K | Sell |
22,116
-229
| -1% | -$7.36K | 0.44% | 57 |
|
|
2017
Q2 | $712K | Sell |
22,345
-2,923
| -12% | -$92.2K | 0.44% | 56 |
|
|
2017
Q1 | $820K | Sell |
25,268
-23,183
| -48% | -$731K | 0.56% | 52 |
|
|
2016
Q4 | $1.49M | Sell |
48,451
-13,117
| -21% | -$400K | 1.21% | 28 |
|
|
2016
Q3 | $1.98M | Buy |
61,568
+8,991
| +17% | +$301K | 1.84% | 17 |
|
|
2016
Q2 | $1.76M | Buy |
52,577
+464
| +0.9% | +$14.8K | 1.85% | 16 |
|
|
2016
Q1 | $1.47M | Buy |
52,113
+6,947
| +15% | +$198K | 1.47% | 20 |
|
|
2015
Q4 | $1.38M | Buy |
45,166
+777
| +2% | +$24.4K | 1.25% | 28 |
|
|
2015
Q3 | $1.32M | Buy |
44,389
+2,732
| +7% | +$87.6K | 1.33% | 22 |
|
|
2015
Q2 | $1.32M | Buy |
41,657
+412
| +1% | +$13.4K | 1.24% | 21 |
|
|
2015
Q1 | $1.36M | Buy |
41,245
+1,853
| +5% | +$58.9K | 1.26% | 18 |
|
|
2014
Q4 | $1.16M | Buy |
+39,392
| New | +$1.13M | 1.1% | 24 |
|
Other funds holding PFE
Canal Capital Management's PFE Position: Q2 2026 in Review
Canal Capital Management reduced its Pfizer (PFE) stake by 0.35% in Q2 2026, selling an estimated $1.1K and leaving 11,866 shares worth $286K. The position accounts for 0.03% of the portfolio, ranked #190.
Canal Capital Management first reported a position in PFE in Q4 2014 and has held it in 45 quarters since. The position peaked at $1.98M in Q3 2016. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Canal Capital Management held 11,866 shares of Pfizer worth $286K as of Q2 2026.
- Canal Capital Management sold 42 Pfizer shares in Q2 2026, an estimated $1.1K.
- Pfizer made up 0.03% of Canal Capital Management's portfolio in Q2 2026, its #190 holding.
- Canal Capital Management first reported a position in Pfizer in Q4 2014 and has held it in 45 quarters since.
- Canal Capital Management's Pfizer position peaked at $1.98M in Q3 2016.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Canal Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.